GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells

MLA

Musong Kim, et al. “GS-5759, a Bifunctional Β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells.” The Journal of Pharmacology and Experimental Therapeutics, vol. 360, no. 2, Sept. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ec5a2ff92e40be17acdbca537369144&authtype=sso&custid=ns315887.

APA

Musong Kim, Mark A. Giembycz, Taruna Joshi, Dong Yan, Robert Newton, Omar Hamed, Gary B. Phillips, Michael Salmon, Clifford D. Wright, & Stacey L. Tannheimer. (2016). GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells. The Journal of Pharmacology and Experimental Therapeutics, 360(2).

Chicago

Musong Kim, Mark A. Giembycz, Taruna Joshi, Dong Yan, Robert Newton, Omar Hamed, Gary B. Phillips, Michael Salmon, Clifford D. Wright, and Stacey L. Tannheimer. 2016. “GS-5759, a Bifunctional Β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells.” The Journal of Pharmacology and Experimental Therapeutics 360 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ec5a2ff92e40be17acdbca537369144&authtype=sso&custid=ns315887.